Cytomegalovirus (CMV) viremia emerges in the majority of CMV seronegative recipients of liver transplants from CMV seropositive donors, most often within the first post-transplant month. The only independent risk factor identified was increasing donor age.
In the United States, rapid diagnostic testing for panels of potential gastrointestinal pathogens in children increases the yield of identifying rare pathogens, but, overall, does not change length of stay for hospitalized patients or reduce hospital charges.
In elderly patients with bacteremic urinary tract infection (UTI), symptoms of UTI were present in only one-third of patients, only four-fifths had fever, and just three-fifths had an early diagnosis of UTI.
A cohort study from the U.S. Department of Veterans Affairs found many survivors of COVID-19 had significant loss of health six months after their acute illness, with greater risk associated with severity of the acute infection.
A patient without apparent immunodeficiency experienced a late relapse of Ebola virus disease with subsequent transmission causing 91 secondary cases. Such late relapse raises concerns regarding control of this disease.